Skip to main content

Table 1 Patient characteristics

From: Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and randomised control study

Variable

Experimental (n = 109)

Control (n = 100)

P

Median age, years (SD)

54.84 (13.44)

59.08 (10.37)

 

Age group

 < 65

83 (55)

68 (45)

0.2172

 ≥ 65

26 (45)

32 (55)

Sex

 Male

69 (63)

61 (61)

0.7761

 Female

40 (37)

39 (39)

Type of cancer

 Nasopharyngeal carcinoma

7 (78)

2 (22)

0.3101

 Lung cancer

26 (44)

33 (56)

 Prostate cancer

21 (50)

21 (50)

 Breast cancer

25 (60)

17 (40)

 Oesophageal cancer

16 (47)

18 (53)

 Gastric cancer

14 (61)

9 (39)

Line of therapy

 1

62 (57)

52 (52)

0.6755

 2

28 (26)

26 (26)

 > 2

19 (17)

22 (22)

ECOG PS

 0–1

93 (85)

88 (88)

0.5701

 2

16 (15)

12 (12)

  1. Data presented as No. (%) unless otherwise indicated
  2. ECOG PS Eastern Cooperative Oncology Group performance status